Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.
Alessi JV, Ricciuti B, Wang X, Pecci F, Di Federico A, Lamberti G, Elkrief A, Rodig SJ, Lebow ES, Eicholz JE, Thor M, Rimner A, Schoenfeld AJ, Chaft JE, Johnson BE, Gomez DR, Awad MM, Shaverdian N.
Alessi JV, et al. Among authors: shaverdian n.
Nat Commun. 2023 Jul 15;14(1):4238. doi: 10.1038/s41467-023-39874-8.
Nat Commun. 2023.
PMID: 37454214
Free PMC article.